Autacoids and Related Drugs: Technologies and Global Markets

Report Code: PHM065A

Publish Date: Apr 2010

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Global sales of autacoids and related drugs reached $94.6 billion in 2009. The market is expected to rise at a compound annual growth rate (CAGR) of 3.2% to reach $112.6 billion by 2015.
    The autacoids market is dominated by biogenic amines, with revenues of $62.9 billion in 2009, and similar expected revenues in 2010.  This market is projected to rise at a compound annual growth rate (CAGR) of 2.5% and reach $71.1 billion by 2015.
  • The second-largest category of autacoids-related drugs is polypeptide autacoids, which generated $20.1 billion in 2009 and are projected to generate $24.9 billion by 2015, for a compound annual growth rate (CAGR) of 3.3%.

INTRODUCTION 

STUDY OBJECTIVES

BCC’s goal in conducting this study is to provide an overview of the current and future characteristics of the global market for autacoids and related products. The key objective is to present a comprehensive analysis of the current market for autacoids and related drugs and its future direction, and to examine the x biologic activity and usage of autacoids in the treatment of various diseases.

This report explores present and future strategies within the autacoids and related drug market, including the biogenic amines, polypeptide derivatives, lipid-derived autacoids, and endothelium-derived autacoids. Market requirements and setbacks in efforts of improvisation are discussed. An overview of autacoids and related products forms the background of this report. 

A detailed analysis of the structure of commerce in autacoids and related products has been conducted. This includes all four major categories of autacoid-related products, further divided into subcategories. Revenues are broken down by region and subcategories. Sales figures are estimated for the 5-year period from 2010 through 2015. 

Applications for autacoids and related products utilizing their theraputic benefits are also discussed separately in the report, with emphasis on results in respiratory, cardiovascular, CNS, analgesics, antiemetics, et al. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

This study was conducted to give insight into, and to categorize autacoids and related products. The industry is undergoing a transition due to generics hitting the market and other new developments. This study was conducted to provide detailed market analysis of autacoids and related products along with the factors affecting this market. As did many industries, autacoids experienced setbacks in 2009 due to the economic downturn as well as patent expirations, but some new advances may influence market growth. This study examines systemic influences in the autacoid market landscape.

Acquisition strategies and collaborations by companies are covered in this report. BCC also discusses the strengths and weaknesses of each category of the market in light of the new technologies/developments, growing competition, and changing customer needs.

INTENDED AUDIENCE

This study delves into the areas of market growth as well as decline in certain categories of autacoids and related products from the point of view of manufacturers and users. Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals, and research institutes will all find this study to be of interest. 

SCOPE OF THE STUDY

The scope of this study encompasses the autacoid-related product manufacturers and various therapeutic medical markets. BCC analyzes each market and its applications by reviewing its regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments. 

METHODOLOGY

BCC conducted a comprehensive literature search that included technical newsletters and journals, and numerous other sources. Data were collected through interviews and correspondence with various analytical/chemical/pharmaceutical/biotechnical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES

Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers as well as end users of autacoids and related products. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.

ABOUT THE AUTHOR

Shalini S Dewan holds a master’s degree in pharmaceutical chemistry. Among the research topics she has covered are studies on compounds from ibuprofen and 2-naphthyl acetic acid that are of potential pharmaceutical interest. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S. Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, An Enduring Market; Advanced Drug Delivery Systems: New Developments, New Technologies; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical Regulatory Industry; and The Dynamic Media, Sera and Reagent Market in Biotechnology.

BCC ONLINE SERVICES

BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  

  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Autacoids and Related Drugs: Technologies and Global Markets242Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY3Free
Chapter- 3: OVERVIEW16Free
Chapter- 4: DRUGS RELATED TO AUTACOIDS21Free
Chapter- 5: REGULATORY ASPECTS7Free
Chapter- 6: INDUSTRY STRUCTURE29Free
Chapter- 7: NEW DEVELOPMENTS13Free
Chapter- 8: MARKET ANALYSIS47Free
Chapter- 9: MARKET BY APPLICATIONS 19Free
Chapter- 10: PATENT ANALYSIS39Free
Chapter- 11: CURRENT SITUATION OF AUTACOID-RELATED DRUGS7Free
Chapter- 12: C. CRAMER & CO. GMBH37Free
Chapter- 13: APPENDIX I-ABBREVIATIONS AND DEFINITIONSFree

Related Reports

Recent Reports

Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - PHM046D

The global market for gastrointestinal (GI) therapeutics and diagnostics is expected to grow from $86.0 billion in 2023 and projected to reach $122.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.3% during the forecast period of 2023 to 2028.

Global Markets and Technologies for Advanced Drug Delivery Systems

Published - Mar 2024 | Publisher - BCC Publishing | Code - PHM006N

The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM113C

The global market for prostate cancer care is expected to grow from $37.9 billion in 2023 to $56.4 billion by the end of 2028, at a compound annual growth rate (CAGR) of 8.3% from 2023 through 2028.

Global Markets for Vaccine Technologies

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM014K

The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.

Chagas Disease: American trypanosomiasis Market

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM282A

The report provides detailed coverage of the Chagas Disease market. It analyzes the market trends and epidemiology of CD, and the regional markets of CD. It highlights the current market for CD and gives a detailed analysis of the competitive environment. The report depicts the complete scenario of Chagas Disease, types of parasites that cause human African trypanosomiasis (HAT) and its presence in various regions of the world.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Medical Robotics and Computer-assisted Surgery: The Global Market

Published - Jun 2024 | Publisher - BCC Publishing | Code - HLC036J

The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Sensors: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - IAS006P

The global market for sensors is estimated to increase from $179.7 billion in 2023 to reach $300.5 billion by 2029, at a compound annual growth rate (CAGR) of 8.9% from 2024 through 2029.

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Water Filtration: Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - MST080B

The global market for water filtration is expected to grow from $10.5 billion in 2024 and is projected to reach $19.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period of 2024 to 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Autacoids and Related Drugs: Technologies and Global Markets
Customize Report